Lung EpiCheck Biomarkers Development Study

Exclusion Criteria

• •Known diagnosis or treatment of cancer from any kind in the past 5 years, except of fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix and except from the current lung cancer
• •\- Known diagnosis or treatment of cancer of any kind in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix
• •Known diagnosis or treatment of cancer of any kind in the past (lifetime), except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix.
• •Not previously diagnosed with a lung lesion highly suspicious for cancer
• •Under follow up or work up for any lesion suspicious for any type of cancer
• •Presenting with fever with body temperature 100.4°F (38°C) or higher
• •Acute exacerbation or flare of an inflammatory condition requiring escalation in medical therapy within 14 days prior to blood draw
• •Pregnancy
• •Any history of blood product transfusion within 30 days prior to blood draw